Actuate Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Actuate Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Actuate Therapeutics, Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3Actuate Therapeutics, Inc (NASDAQ:ACTU) IPO will take place August, 08 on the NASDAQ exchange under the ticker ACTU.
Actuate Therapeutics，Inc（納斯達克代碼：ACTU）的IPO將於8月8日在納斯達克交易所上市，代碼爲逐筆明細。
The company is offering shares at an expected price between $8.00 and $10.00 per share with an insider lock-up period of 180 days ending on February 04, 2025.
該公司將以每股8.00至10.00美元的預期價格提供股份，內部人士鎖定期爲180天，截止日期爲2025年2月4日。
See also: Benzinga IPO Calendar
參見：Benzinga IPO日曆
About Actuate Therapeutics, Inc
關於Actuate Therapeutics, Inc
Actuate Therapeutics, Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3
Actuate Therapeutics，Inc是一家臨床階段的生物製藥公司，專注於通過抑制糖原合成酶激酶-3的活性，開發治療高影響力難治性癌症的療法。
See also: Benzinga's Most Shorted Stocks
參見：Benzinga的做空集合股
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動化內容引擎生成並由編輯審查。
譯文內容由第三人軟體翻譯。
